Close-up of an the ICR logo on a research centre

Centre for In Vivo Modelling

The Centre for In Vivo Modelling is a newly established research centre within the Division of Cancer Biology at the ICR. Our scientists and clinical researchers use state-of-the-art in vivo models to address fundamental questions in cancer biology, with the ultimate aim of identifying curative treatments. We also serve as a collaborative hub across the ICR and The Royal Marsden, providing cutting-edge expertise in advanced mouse genetics and humanised in vivo models of cancer.

Professor Kamil R Kranc, Chair of Haemato-Oncology, serves as the Centre's Director, while Fabiana Muzzonigro is the Centre Administrator.

 

How we conduct research at this centre

Solid tumours and blood cancers are highly complex ecosystems, with many composed of varying cell types including rare cancer stem cells at the apex of a hierarchical organisation, more differentiated malignant progeny, and a dynamic microenvironment that nurtures tumour growth and survival. At our Centre, we seek to elucidate the fundamental principles that govern this malignant ecosystem. We employ advanced mouse genetics (including barcoding and lineage tracing) and PDX models to dissect how tumour cells function, evolve under selective pressures, evade therapy, and engage with their microenvironment to sustain disease progression. By decoding these intricate cellular and molecular interactions, we aim to identify transformative therapeutic strategies capable of eradicating cancer at its origin - achieving durable remission while preserving normal tissue integrity.

A particular strength of our Centre lies in the generation and application of in vivo models, which are essential for uncovering novel aspects of cancer biology and evaluating emerging therapies. We work in close collaboration with ICR researchers and clinicians at The Royal Marsden to develop patient-derived xenograft (PDX) models of leukaemias and solid tumours by transplanting human cancer tissue into immunocompromised mice. In parallel, we generate and utilise genetically engineered mouse models (GEMMs) to interrogate cancer biology in a physiologically relevant context. By leveraging these sophisticated in vivo systems, the Centre aims to:

  • Uncover new facets of cancer biology in a complex in vivo ecosystem
  • Discover and validate novel therapeutic targets allowing for elimination of cancer stem cells and their malignant progeny in blood cancers and solid tumours
  • Collaborate closely with drug discovery teams at the ICR to develop inhibitors of these targets
  • Evaluate new anti-cancer drugs in pre-clinical in vivo models, paving the way for clinical trials.

In addition to our academic focus, CIVM serves as a collaborative hub across the ICR and The Royal Marsden, providing the ICR community with cutting-edge expertise in advanced mouse genetics and humanised mouse models of cancer.

Join us

We are recruiting two exceptional Group Leaders to join the Division of Cancer Biology and the Centre for In Vivo Modelling (CIVM). This is a unique opportunity to shape the future of cancer biology research, lead innovative programmes, and make discoveries that transform patient outcomes.

These new Group Leaders will investigate fundamental mechanisms of tumour initiation, progression, and treatment resistance, and develop cutting-edge preclinical models to advance understanding of cancer biology. Working in close collaboration across the ICR and The Royal Marsden Hospital, the postholders will translate discovery science into new therapeutic opportunities, contributing to the ICR’s mission to make the discoveries that defeat cancer.

Find out more about the vacancies

Members of this Centre

Pipettes and well plates

In Vivo Modelling core

We provide cutting-edge expertise in advanced mouse genetics and humanized mouse models of cancer.

CIVM Service Core

Other staff:

Driving discovery through collaboration 

At CIVM, our collaborative spirit drives our mission to advance cancer cures. We actively partner with basic science, translational, and clinical research groups across the ICR and The Royal Marsden. Our collaborations also extend beyond, working closely with distinguished academic teams at the Universities of Oxford, Cambridge, Edinburgh, Cardiff, London, Glasgow, and the Francis Crick Institute.

 

News from the Centre

We are recruiting a Group Leader in In Vivo Cancer Modelling. We welcome applications at both the Career Development Faculty and Career Faculty levels. Competitive start up package is available. For further particulars please contact [email protected].

 

 

Current vacancies

Group Leader in In Vivo Cancer Modelling

  • Sutton
  • Cancer Biology
  • From £66,092 per annum
  • Fixed term

The Institute of Cancer Research (ICR) in London seeks to appoint a Group Leader in In Vivo Cancer Modelling to play a pivotal role in advancing our cutting-edge cancer research. The position is based at the newly established Centre for In Vivo Modelling (CIVM), part of the Division of Cancer Biology. We welcome applications at both the Career Development Faculty and Career Faculty levels. Key Requirements The successful candidate will generate and employ state-of-the-art genetic and humanised mouse models of cancer to tackle fundamental and translational questions in haemato-oncology and/or solid tumour oncology. In addition to leading a successful research group, they will expand the CIVM's research capabilities and foster productive collaborations with other groups and centres at the ICR, thus promoting in vivo modelling by integrating it into multidisciplinary projects and initiatives. Applicants must have an internationally recognised track record of leading research in in vivo modelling and advanced mouse genetics, demonstrated by high-quality publications and significant funding success. For more junior candidates, an outstanding track record in cancer research, coupled with a compelling research vision leveraging advanced genetic mouse models and clear potential to secure competitive external funding, is essential. As part of your online application you will be required to upload your full CV which will pre-populate your application form, you will also be asked to attach the following documents and failure to do so will mean your application cannot be considered on this occasion: Lists of major publications, achievements, research grants, distinctions. Research plan (five to six pages outlining your current research interests and research programme for the next 5 years) A PDF of a maximum of five key publications, or other research outputs (e.g. patents) that best demonstrate previous productivity You must also complete the personal statement section of the application form in the format of a covering letter including the names and contact details of three academic referees Department/Directorate Information: Cancer Biology Division Information The ICR is one of the world’s most influential cancer research institutions, with an outstanding track record of achievement dating back more than 100 years. In addition to being one of the UK’s leading higher education institutions for research quality and impact, the ICR is consistently ranked among the world’s most successful for industry collaboration. As a member institution of the University of London, we also provide postgraduate higher education of international distinction. One of the ICR’s key research strategies is to defeat cancer by viewing it as a dynamic ecosystem. We aim to solidify our expertise in state-of-the-art in vivo cancer models to probe these complex cancer ecosystems, discover their underlying biology, and identify new therapeutic targets. The postholder will significantly contribute to driving these strategic priorities. We encourage all applicants to access the job pack attached for more detailed information regarding this role. If you would like to informally discuss this position, please contact Professor Kamil R. Kranc ([email protected]), Director of the Centre for In Vivo Modelling, or Professor Chris Jones ([email protected]), Head of the Division of Cancer Biology at the ICR.

Group Leader in Cancer Stem Cell Biology

  • Sutton
  • Cancer Biology
  • Competitive
  • Permanent

Key Requirements As part of your online application you will be required to upload your full CV which will pre-populate your application form, you will also be asked to attach the following documents and failure to do so will mean your application cannot be considered on this occasion: Lists of major publications, achievements, research grants, distinctions. Research plan (five to six pages outlining your current research interests and research programme for the next 5 years) A PDF of a maximum of five key publications, or other research outputs (e.g. patents) that best demonstrate previous productivity You must also complete the personal statement section of the application form in the format of a covering letter including the names and contact details of three academic referees Department/Directorate Information: Cancer Biology Information The Institute of Cancer Research (ICR) in London seeks to appoint a Group Leader in Cancer Stem Cell Biology to play a pivotal role in advancing our cutting-edge cancer research. The position will be based in newly-refurbished laboratory and office space at our Sutton campus within the Division of Cancer Biology. We welcome applications at both the Career Development Faculty and Career Faculty levels. The ICR is one of the world’s most influential cancer research institutions, with an outstanding track record of achievement dating back more than 100 years. In addition to being one of the UK’s leading higher education institutions for research quality and impact, the ICR is consistently ranked among the world’s most successful for industry collaboration. As a member institution of the University of London, we also provide postgraduate higher education of international distinction. One of the ICR’s key research strategies is to defeat cancer by viewing it as a dynamic ecosystem. We aim to solidify our expertise in the biology of cancer stem cells. The postholder will significantly contribute to understanding the underlying biology of cancer stem cells and how this may be exploited to address key questions in tumour relapse, disease progression and metastasis. The successful candidate will have a compelling research programme focused on cancer stem cell biology in an area which complements existing disease-specific expertise at the ICR / Royal Marsden NHS trust. Possible areas of research include (but are not restricted to) basic mechanisms of self-renewal and pluripotency, regulation of cancer stem cell fate / differentiation, how they remodel the tumour microenvironment into a supportive niche, targeting treatment resistance of cancer stem cells, and the role of CSCs in driving the metastatic cascade. Applicants must have an internationally recognised track record of leading research in cancer stem cell biology, demonstrated by high-quality publications and significant funding success. For more junior candidates, an outstanding postdoctoral track record in cancer research, coupled with a compelling research vision in a strategic area of cancer stem cell biology and clear potential to secure competitive external funding, is essential. If you would like to informally discuss this position, please contact Professor Chris Jones ([email protected]), Head of the Division of Cancer Biology at the ICR.

Data Scientist

  • Sutton
  • Cancer Biology
  • £39,805 - £53,500
  • Fixed term

Under the guidance of Professor Trevor Graham, we are seeking to recruit a Data Scientist to support Data Science research across the ICR. The successful candidate will have particular work on the analysis of spatial data (including multiplex immunohistochemistry, H&Es and spatial transcriptomics) and will be required to stay abreast of new developments in the field and provide training to colleagues. About you The successful candidate must have: A PhD in quantitative subject, or likely to be awarded PhD in the near future. Research experience equivalent to PhD level will be considered. Undergraduate degree, or Masters or equivalent in a quantitative subject. Skills in bioinformatics computing coding, in languages including R, Python and other scripting languages as is appropriate. Experience of using high performance computing (HPC) systems for scientific computing. Experience of computational biology research methodologies pertinent to the role. Department/Directorate Information The Data Science Committee is chaired by Professor Trevor Graham, providing academic leadership of data science at the ICR to maximise the impact of our cancer research, by applying innovative data science and computation tools (in addition to our traditional areas of strength) to tackle the important cancer questions and ensuring infrastructure is considered to enable this. What we offer A dynamic and supportive research environment Access to state-of-the-art facilities and professional development opportunities Collaboration with leading researchers in the field Competitive salary and pension We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Prof Trevor Graham [email protected].

News from the ICR

28/01/26

The Institute of Cancer Research, London, is the joint recipient of a major new Medical Research Council (MRC) grant to advance how sensitive medical imaging data can be used for research.

An award of nearly £400,000 will fund the Federated Infrastructure for digital pathology Reporting and Expert Data Annotation in a Secure Environment (FIREDANSE) project, run in collaboration with The Royal Marsden NHS Foundation and Imperial College. FIREDANSE will form part of the newly announced portfolio of Data and Analytics Research Environments UK (DARE UK) Phase 2 catalysts, funded through UK Research and Innovation (UKRI).

This award sits within a wider £2.5 million investment across eight pioneering projects, which will run for 12 months and are intended to test bold, early‑stage ideas that could shape the future of UK data research infrastructure. The programme will push the boundaries of technology in the next generation of Trusted Research Environments (TREs) – highly secure digital platforms that allow approved researchers to access sensitive data safely and responsibly.  

Linking digital pathology data across Trusts

While today’s secure environments protect privacy and maintain public trust, they can limit the data types, tools and computational power available to researchers. The newly funded projects aim to explore how these restrictions might be safely overcome, opening the door to research questions that are currently difficult, or even impossible, to answer. The outputs will include prototypes, evidence and practical guidance to inform national policy and long‑term infrastructure planning.

FIREDANSE is led by Professor Manuel Salto-Tellez, Professor of Integrative Pathology, and Dr Simon Doran, Senior Staff Scientist in the Division of Radiotherapy and Imaging, both at The Institute of Cancer Research (ICR). Together with their co-investigators and collaborators, they will demonstrate the feasibility of securely linking biopsy images and associated clinical data across the TREs of two major cancer centres: The Royal Marsden’s BRIDgE TRE and the NIHR Imperial Biomedical Research Centre funded iCARE secure data environment.

By enabling these data connections across institutions, the team plans to show how future researchers could train more powerful artificial intelligence (AI) models to improve cancer diagnosis and treatment. The linked datasets will allow algorithms to learn from a greater variety of patient cases, making them more accurate and clinically useful. Such advances may ultimately help alleviate the severe workforce pressures facing pathology services both in the UK and internationally.

Expert review to address patient concerns about AI

A core element of the FIREDANSE project focuses on responding to patient and public concerns about the reliability of medical AI systems. People want to know that any AI used in healthcare is closely overseen and validated by hospital consultants throughout both development and deployment. They also want reassurance that there is no significant risk of algorithms generating inaccurate or misleading results.

To address this, the team will adapt an existing web‑based app developed at the ICR that allows consultants to view anonymised pathology images and clinical data securely, and to enter expert reviews in a structured and efficient way. The upgraded platform will work seamlessly across both The Royal Marsden and Imperial, enabling multi‑hospital expert validation of AI models. This will support not only algorithm development but also ongoing quality assurance, ensuring that AI tools perform consistently and safely in clinical settings.

Public engagement and governance

Public involvement is central to the project. FIREDANSE will run engagement activities to better understand public priorities and concerns, introduce participants to the language and concepts of AI in healthcare, and facilitate discussions among citizens, clinicians and data scientists. The aim is to help build trust while demystifying the complexities involved in securely protecting sensitive data within institutional boundaries, even as researchers collaborate across sites.

The team will present its engagement materials to information governance professionals at partner organisations. Their approval will be required for the test system to be used more widely, offering an early indication of whether the project’s communication approach meets the needs of both experts and non‑specialists.

Building the future of secure data research

Announcing the funding, Emily Jefferson, Interim Director of DARE UK, said:

“These projects are intentionally exploratory. They give researchers the freedom to test bold ideas that challenge current assumptions about how Trusted Research Environments work. By investing in early‑stage prototypes and strong public engagement, we are building the evidence needed to shape future infrastructure that is secure, flexible and worthy of public trust.”

The findings from FIREDANSE and the other funded projects will be shared widely across the research community. The aim is to guide the future direction of DARE UK and shape national and sector‑wide approaches to securing data research, helping ensure that the UK remains a global leader in the safe, responsible and innovative use of sensitive health data.

Dr Simon Doran, Senior Staff Scientist in the Division of Radiotherapy and Imaging, at The Institute of Cancer Research, London said:

“It’s a huge honour to receive this award, and we are immensely grateful to the MRC for continuing to fund research that has a real-world impact.

“Our project’s name, inspired by the Balinese fire dance, symbolises the careful choreography required to move sensitive data safely between secure environments – a balancing act of jeopardy, precision, coordination and technical mastery. In the same spirit, we aim to demonstrate how cutting‑edge data infrastructure can support better research while protecting the privacy and trust of the patients at its heart.”

Erik Mayer, Clinical Associate Professor and Director of the iCARE Secure Data Environment at Imperial, said:

“We are very grateful to DARE UK for funding this work that will help us continue to develop a fully interoperable national network of secure data research infrastructures for public and patient benefit.”

Steven Francis, Chief Information Officer at The Royal Marsden NHS Foundation Trust, said: 

“Allowing access to data for collaborative research projects, whilst retaining complete control of anonymised patient data, is a major challenge for the world's leading healthcare institutions. We are very grateful to DARE UK for funding this work, as FIREDANSE will create new technology to ensure the UK remains at the forefront of this field whilst reassuring the public that their data is being used responsibly.”

Image credit: Brian Penny from Pixabay